A review of monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection.
Hum Antibodies
; 29(3): 179-191, 2021.
Article
in English
| MEDLINE | ID: covidwho-1226968
ABSTRACT
The harmful COVID-19 pandemic caused by the SARS-CoV-2 coronavirus imposes the scientific community to develop or find conventional curative drugs, protective vaccines, or passive immune strategies rapidly and efficiently. Passive immunity is based on recovering hyper-immune plasma from convalescent patients, or monoclonal antibodies with elevated titer of neutralizing antibodies with high antiviral activity, that have potential for both treatment and prevention. In this review, we focused on researching the potentiality of monoclonal antibodies for the prevention and treatment of COVID-19 infection. Our research review includes antibody-based immunotherapy, using human monoclonal antibodies targeting SARS-CoV-2 viral protein regions, specifically the spike protein regions, and using hyper-immune plasma from convalescent COVID-19 patients, in which monoclonal antibodies act as immunotherapy for the cytokine storm syndrome associated with the COVID-19 infection. In addition, we will demonstrate the role of the monoclonal antibodies in the development of candidate vaccines for SARS-CoV-2. Moreover, the recent progress of the diagnostic mouse monoclonal antibodies' role will be highlighted, as an accurate and rapid diagnostic assay, in the antigen detection of SARS-CoV-2. In brief, the monoclonal antibodies are the potential counter measures that may control SARS-CoV-2, which causes COVID-19 disease, through immunotherapy and vaccine development, as well as viral detection.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Immunization, Passive
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19 Drug Treatment
/
Antibodies, Monoclonal
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Hum Antibodies
Journal subject:
Allergy and Immunology
Year:
2021
Document Type:
Article
Affiliation country:
Hab-200441
Similar
MEDLINE
...
LILACS
LIS